Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cerilliant
US Army
Cipla
Moodys
Harvard Business School
McKesson
UBS
Citi

Generated: July 16, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Jantoven

« Back to Dashboard

Bulk Pharmaceutical API Sources for Jantoven

Vendor Vendor Homepage Vendor Sku API Url
ChemBridge ➤ Try a Free Trial 5103026 ➤ Try a Free Trial
NovoSeek ➤ Try a Free Trial 16204922 ➤ Try a Free Trial
TCI (Tokyo Chemical Industry) ➤ Try a Free Trial W0005 ➤ Try a Free Trial
MolPort ➤ Try a Free Trial MolPort-002-130-141 ➤ Try a Free Trial
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Moodys
Express Scripts
Teva
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.